<DOC>
	<DOCNO>NCT00001439</DOCNO>
	<brief_summary>This phase I study melanoma tumor antigen peptide vaccine . The nine amino acid peptide represent HLA-A2 restrict T cell epitope melanoma antigen , gp100 administer patient emulsify Incomplete Freund 's Adjuvant , ( IFA ) . The study design evaluate toxicity , immunologic effect potential therapeutic role repeat dos gp100 peptide vaccine administer subcutaneously . Immune reactivity gp100 epitope peptide monitor patient analysis melanoma-specific T cell precursor frequency prior immunization .</brief_summary>
	<brief_title>A Phase I Study gp100 Human Melanoma Peptide Vaccine With Incomplete Freund 's Adjuvant</brief_title>
	<detailed_description>This phase I study melanoma tumor antigen peptide vaccine . The nine amino acid peptide represent HLA-A2 restrict T cell epitope melanoma antigen , gp100 administer patient emulsify Incomplete Freund 's Adjuvant , ( IFA ) . The study design evaluate toxicity , immunologic effect potential therapeutic role repeat dos gp100 peptide vaccine administer subcutaneously . Immune reactivity gp100 epitope peptide monitor patient analysis melanoma-specific T cell precursor frequency prior immunization .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Freund 's Adjuvant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Metastatic melanoma HLAA2 positive . No primary melanoma ocular mucosal origin . Measurable resect metastatic disease require . PRIOR/CONCURRENT THERAPY : BIOLOGIC THERAPY : No prior ( great 30 day ) concurrent Biologic Therapy . CHEMOTHERAPY : No prior ( great 30 day ) concurrent chemotherapy . ENDOCRINE THERAPY : No prior ( great 30 day ) concurrent hormone therapy . No requirement steroid . RADIOTHERAPY : No prior ( great 30 day ) concurrent radiotherapy . SURGERY : Not specify . PATIENT CHARACTERISTICS : Age : 18 . Performance Status : ECOG 0 1 . Life Expectancy : More 3 month . HEMATOPOIETIC : No coagulation disorder . HEPATIC : Bilirubin great 2.0 mg/dL . No Hepatitis BsAg antibody . RENAL : Creatinine great 2.0 mg/dL . CARDIOVASCULAR : No major cardiovascular illness . PULMONARY : No major respiratory illness . OTHER : No previous allergic reaction incomplete Freund 's adjuvant . HIV negative . No active systemic infection . Not pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Immunotherapy</keyword>
</DOC>